Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles - PubMed (original) (raw)

Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles

C Carrière et al. J Virol. 1995 Apr.

Abstract

Interacting domains in human immunodeficiency virus type 1 (HIV-1) Gag precursor (Pr55gag) expressed in recombinant baculovirus-infected cells were investigated by three different methods: (i) trans rescue and coencapsidation of C-terminal deletion (amber) Gag mutants and Gag chimeras into retrovirus-like particles in complementation experiments with HIV-1 wild-type (WT) Pr55gag, (ii) Gag-Gag interactions in vitro in Gag ligand affinity blotting assays, and (iii) quantitative immunoelectron microscopy of retrovirus-like Gag particles, using a panel of monoclonal antibodies to probe the epitope accessibility of encapsidated HIV-1 WT Pr55gag. Four discrete regions, within residues 210 to 241, 277 to 306 (major homology region), and 307 to 333 in the capsid (CA) protein and residues 358 to 374 at the CA-spacer peptide 2 (sp2) junction, were found to have a significant influence on Gag trans-packaging efficiency. A fifth region, within residues 375 to 426, overlapping the sp2-nucleocapsid (NC) protein junction and most of the NC, seemed to be essential for stable inter-Gag binding in vitro. The coincidence of the two regions from 358 to 374 and 375 to 426 with an immunologically silent domain in WT Gag particles suggested that they could participate in direct Gag interactions.

PubMed Disclaimer

Cited by

Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation.
Cimarelli A, Sandin S, Höglund S, Luban J. Cimarelli A, et al. J Virol. 2000 May;74(9):4273-83. doi: 10.1128/jvi.74.9.4273-4283.2000. J Virol. 2000. PMID: 10756042 Free PMC article.
Tyrosine kinase-dependent release of an adenovirus preterminal protein complex from the nuclear matrix.
Angeletti PC, Engler JA. Angeletti PC, et al. J Virol. 1996 May;70(5):3060-7. doi: 10.1128/JVI.70.5.3060-3067.1996. J Virol. 1996. PMID: 8627784 Free PMC article.
Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein.
Konvalinka J, Löchelt M, Zentgraf H, Flügel RM, Kräusslich HG. Konvalinka J, et al. J Virol. 1995 Nov;69(11):7264-8. doi: 10.1128/JVI.69.11.7264-7268.1995. J Virol. 1995. PMID: 7474150 Free PMC article.
Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly.
Morikawa Y, Hockley DJ, Nermut MV, Jones IM. Morikawa Y, et al. J Virol. 2000 Jan;74(1):16-23. doi: 10.1128/jvi.74.1.16-23.2000. J Virol. 2000. PMID: 10590086 Free PMC article.
Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.
Burniston MT, Cimarelli A, Colgan J, Curtis SP, Luban J. Burniston MT, et al. J Virol. 1999 Oct;73(10):8527-40. doi: 10.1128/JVI.73.10.8527-8540.1999. J Virol. 1999. PMID: 10482606 Free PMC article.

References

1. J Virol. 1994 Jan;68(1):111-22 - PubMed
1. J Virol. 1993 Nov;67(11):6487-98 - PubMed
1. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
1. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 - PubMed
1. Cell. 1985 Jan;40(1):9-17 - PubMed

Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles - PubMed (original) (raw)